Associated Papers
Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers.
Kluitmans DJF et al.
Frontiers in Oncology, 2025
41199836 (PubMed )
Supplement: Table1.xlsx › Cell_line_information
Multiplex single-cell chemical genomics reveals the kinase dependence of the response to targeted therapy.
McFaline-Figueroa JL et al.
Cell Genomics, 2024
Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2.
Enrico TP et al.
Elife, 2021
The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication.
Michaelis M et al.
Cellular and Molecular Life Sciences : Cmls, 2011
Select a paper to view details